Africa: Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of Hmbd-001 in Her3 Driven Cancers

[PR Newswire] Singapore -HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies

Leave a Reply

Your email address will not be published. Required fields are marked *

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.